Test Helps Tailor Therapy
The Journal of Clinical Oncology recently released study results from the Lombardi Comprehensive Cancer Center at Georgetown University in Washington, DC.
In this study, researchers found the use of a blood test helped doctors tailor therapy to metastic breast cancer patients. The test involves the use of Veridex's CellSearch technology, which measures the number of circulating tumor cells (CTC) in the blood. The physicians found a high correlation between the CTC results and radiographic tests.
Check out this article in Science Daily for more information on the study.